/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Larimar Therapeutics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$3.47 0.1122(11.22%) LRMR at 04 Dec 2025 04:37 PM Biotechnology
Lowest Today 3.14
Highest Today 3.485
Today’s Open 3.18
Prev. Close 3.12
52 Week High 6.91
52 Week Low 1.61
Day’s Range: Low 3.14 High 3.485
52-Week Range: Low 1.61 High 6.91
1 day return -
1 Week return -2.11
1 month return -8.55
3 month return -10.2
6 month return +42.41
1 year return -42.75
3 year return +7.25
5 year return -86.29
10 year return -

Institutional Holdings

Deerfield Management Co 24.81

RA Capital Management, LLC 7.06

Blue Owl Capital Holdings LP 5.76

Opaleye Management Inc 4.80

Millennium Management LLC 4.27

BlackRock Inc 3.55

Vanguard Group Inc 2.50

Alyeska Investment Group, L.P. 2.43

Vanguard Total Stock Mkt Idx Inv 2.28

Citadel Advisors Llc 1.56

Two Sigma Advisers, LLC 1.34

iShares Russell 2000 ETF 1.25

Geode Capital Management, LLC 1.06

Two Sigma Investments LLC 1.06

State Street Corp 1.00

Mangrove Partners 0.90

Caption Management, LLC 0.81

Woodline Partners LP 0.73

Verition Fund Managegment, LLC 0.66

Renaissance Technologies Corp 0.66

Driehaus Capital Management LLC 0.63

AQR Capital Management LLC 0.50

Fidelity Small Cap Index 0.50

iShares Russell 2000 Value ETF 0.43

Vanguard Institutional Extnd Mkt Idx Tr 0.41

iShares Biotechnology ETF 0.26

Vanguard Russell 2000 ETF 0.24

Fidelity Extended Market Index 0.20

State St Russell Sm Cap® Indx SL Cl I 0.16

CREF Stock R3 0.14

Schwab Small Cap Index 0.13

NT R2000 Index Fund - NL 0.12

Bridgeway Ultra-Small Company Market 0.11

iShares Micro-Cap ETF 0.11

NT R2000 Index Fund - DC - NL - 3 0.10

Avantis US Small Cap Equity ETF 0.09

Extended Equity Market Fund K 0.09

SPDR® Russell 2000 US Small Cap ETF 0.08

iShares Russell 2000 Small-Cap Idx Instl 0.08

Russell 2500™ Index Fund F 0.08

Market Status

Strong Buy: 10

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 267.04 M

PB Ratio 2.1792

PE Ratio 0.0

Enterprise Value 131.90 M

Total Assets 200.23 M

Volume 1377085

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-33381000 -33.4M, FY22:-34184000 -34.2M, FY21:-50310000 -50.3M, FY20:-42327000 -42.3M, FY19:-23132000 -23.1M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-87000 -0.1M, Q1/2025:-88000 -0.1M, Q3/2024:-74000 -0.1M, Q2/2024:-87000 -0.1M

Quarterly Net worth Q3/2025:-47712000 -47.7M, Q2/2025:-26182000 -26.2M, Q1/2025:-29281000 -29.3M, Q3/2024:-15499000 -15.5M, Q2/2024:-21627000 -21.6M

Fund house & investment objective

Company Information Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Organisation Biotechnology

Employees 65

Industry Biotechnology

CEO Dr. Carole S. Ben-Maimon M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow